NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma
NCI 8628:一项随机 II 期研究,比较 ziv-aflibercept 联合高剂量白细胞介素 2 或单独使用高剂量白细胞介素 2 治疗无法手术的 III 期或 IV 期黑色素瘤的疗效。
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.31734
Tarhini, Ahmad A; Frankel, Paul; Ruel, Christopher; Ernstoff, Marc S; Kuzel, Timothy M; Logan, Theodore F; Khushalani, Nikhil I; Tawbi, Hussein A; Margolin, Kim A; Awasthi, Sanjay; Butterfield, Lisa H; McDermott, David; Chen, Alice; Lara, Primo N; Kirkwood, John M